The Cysteine Protease Activity of the Major Dust Mite Allergen Der P 1 Selectively Enhances the Immunoglobulin E Antibody Response by Gough, Lucy et al.
 
1897
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/99/12/1897/05 $5.00
Volume 190, Number 12, December 20, 1999 1897–1901
http://www.jem.org
 
Brief Deﬁnitive Report
 
The Cysteine Protease Activity of the Major Dust Mite 
Allergen Der
 
 
 
p
 
 
 
1 Selectively Enhances the Immunoglobulin E 
Antibody Response
 
By Lucy Gough, Oliver Schulz, Herb F. Sewell, and Farouk Shakib
 
From the Division of Molecular and Clinical Immunology, Faculty of Medicine and Health Sciences, 
University of Nottingham, Queen’s Medical Centre, Nottingham NG7 2UH, United Kingdom
 
Summary
 
The house dust mite 
 
Dermatophagoides pteronyssinus
 
 allergen Der
 
 
 
p
 
 
 
1 is the most immunodomi-
nant allergen involved in the expression of dust mite–specific immunoglobulin (Ig)E–mediated
hypersensitivity. The reason for this potent IgE-eliciting property of Der
 
 
 
p
 
 
 
1 remains unknown,
but there is mounting in vitro evidence linking the allergenicity of Der
 
 
 
p
 
 
 
1 to its cysteine pro-
tease activity. Here we demonstrate for the first time that immunization of mice with pro-
teolytically active Der
 
 
 
p
 
 
 
1 results in a significant enhancement in total IgE and Der
 
 
 
p
 
 
 
1–specific
IgE synthesis compared with animals immunized with Der
 
 
 
p
 
 
 
1 that was irreversibly blocked
with the cysteine protease inhibitor E-64. We conclude that the proteolytic activity of Der
 
 
 
p
 
 
 
1
is a major contributor to its allergenicity.
Key words: cysteine protease • Der
 
 
 
p
 
 
 
1 • IgE
 
I
 
mmunoglobulin E plays a central role in the sequence of
events leading to allergic hypersensitivity disorders such
 
as asthma that afflict 
 
z
 
20% of the world population (1). The
house dust mite 
 
Dermatophagoides pteronyssinus
 
 allergen Der
p
 
 
 
1 has long been recognized as the most immunodominant
allergen involved in the expression of dust mite–specific
IgE–mediated hypersensitivity (2). The reason for this po-
tent IgE-eliciting property of Der
 
 
 
p
 
 
 
1 remains unknown,
but there is mounting evidence linking the allergenicity of
Der
 
 
 
p
 
 
 
1 to its cysteine protease activity (3).
Recent in vitro work has established that Der
 
 
 
p
 
 
 
1 selec-
tively cleaves human CD25, the 55-kD 
 
a
 
 subunit of the T
cell IL-2 receptor (the high-affinity form of which consists
of 
 
a
 
, 
 
b
 
, and 
 
g
 
 subunits) (4). As a result of cleavage of sur-
face CD25, peripheral blood T cells show markedly dimin-
ished proliferation and IFN-
 
g
 
 secretion in response to
stimulation by anti-CD3 antibody. It is known that CD4
Th cells undergo a cytokine-driven process of polarization
and that IL-2, along with IFN-
 
g
 
, and IL-4 are considered
to be autocrine growth factors for the Th1 and Th2 subsets,
respectively (5). The Th1 and Th2 cell populations promote
the development of cells of the same subset while suppress-
ing the propagation of those of the other subset. Therefore,
Der
 
 
 
p
 
 
 
1–induced cleavage of CD25 is likely to lead to im-
paired growth of cells of the Th1 subset and consequent
augmentation of those of the Th2 subset.
These observations raise the question of whether the
cysteine protease activity of Der
 
 
 
p
 
 
 
1 would bias the im-
mune response in favor of IgE. In this paper, we demon-
strate that immunization of mice with proteolytically active
Der
 
 
 
p
 
 
 
1 results in a significant enhancement in total IgE
and Der
 
 
 
p
 
 
 
1–specific IgE synthesis compared with animals
immunized with Der
 
 
 
p
 
 
 
1 that was irreversibly blocked with
the cysteine protease inhibitor E-64.
 
Materials and Methods
 
Der p 1 Preparation.
 
Der
 
 
 
p
 
 
 
1 was isolated from house dust mite
fecal pellets (Allergon) by a multistep procedure (6) involving im-
munoaffinity chromatography on immobilized anti–Der
 
 
 
p
 
 
 
1 mAb
(clone 4C1; Indoor Biotechnologies), removal of contaminating
serine proteases on immobilized soybean trypsin inhibitor (Sigma
Chemical Co.), and finally fast protein liquid chromatography
(FPLC) to remove low-molecular-mass contaminants. The purity
of the preparation was confirmed by NH
 
2
 
-terminal sequencing
on an automatic amino acid sequencer (Applied Biosystems, Inc.),
SDS-PAGE analysis (15% gel), and demonstration that enzymatic
activity was completely dependent on preactivation with cysteine
and totally inhibited by E-64 (
 
l
 
-trans-epoxysuccinyl-leucylamido
[4-guanidino]butane). Protein concentration was determined using
a bicinchoninic acid (BCA) microtiter plate assay and confirmed
spectrophotometrically using the empirical absorption coefficient
value for Der
 
 
 
p
 
 
 
1 of E
 
1% 
 
(280 nm) 
 
5 
 
16.4.
Before use, Der
 
 
 
p
 
 
 
1 was preactivated with 5 mM cysteine
(Sigma Chemical Co.) to regenerate its thiol group, which be-
comes oxidized during purification. The catalytic activity of Der
p
 
 
 
1 was ascertained in a continuous rate (kinetic) assay using the
fluorogenic peptide substrate 
 
N
 
-tert-butoxy-carbonyl (Boc)-Gln-
Ala-Arg–7-amino-4-methyl-coumarin (AMC; reference 6). To
block the proteolytic activity of cysteine-activated Der
 
 
 
p
 
 
 
1,
1,000-fold molar excess of E-64 (Sigma Chemical Co.) was used;
a similar molar ratio of the cysteine protease inhibitor iodoaceta- 
1898
 
Der p 1 Enhances IgE
mide (Sigma Chemical Co.) was used as another sulfhydryl reac-
tive agent.
 
CD25 Cleavage.
 
Spleen T cells were obtained from C57BL/6J
mice using standard procedures. The cells (2 
 
3
 
 10
 
6
 
) were sus-
pended in RPMI (GIBCO Life Technologies) and stimulated for
3 d at 37
 
8
 
C with Con A (5 
 
m
 
g/ml final concentration) in the pres-
ence of IL-2 (100 U/ml) in a humidified atmosphere of 5% CO
 
2
 
.
CD25 cleavage was performed by incubating 10
 
5 
 
cells with up to
10 
 
m
 
g/ml Der
 
 
 
p
 
 
 
1 (preactivated with 5 mM cysteine) for 1 h at
37
 
8
 
C in a total volume of 200 
 
m
 
l serum-free AIM V medium
(GIBCO Life Technologies). The cells were then resuspended in
RPMI containing 2% FCS, stained for 45 min at room tempera-
ture in the dark with FITC-labeled anti–mouse CD25 mAb (clone
AMT-13; Sigma Chemical Co.), and fixed with 5% formalde-
hyde. Cells were analyzed on a FACScan™ (Becton Dickinson)
as described (4). The expression of other T cell surface markers,
namely CD3, CD4, and CD8, was monitored in the same way
using appropriate PE- or FITC-labeled antibodies (clone KT3,
Beckman Coulter; and clones YTS191.1 and KT15 [Serotec Ltd.],
respectively).
 
Immunization Protocol.
 
Five groups of 10 female CBA/J mice
were given six weekly intraperitoneal injections of 10 
 
m
 
g of pro-
teolytically active Der
 
 
 
p
 
 
 
1, 10 
 
m
 
g of E-64–blocked Der
 
 
 
p
 
 
 
1, 10
 
m
 
g of iodoacetamide-blocked Der
 
 
 
p
 
 
 
1, 10 
 
m
 
g of OVA (as pro-
teolytically inactive antigen; Sigma Chemical Co.), or 10 
 
m
 
g of
OVA with E-64, respectively. All immunizations were given in
200 
 
m
 
g of Al(OH)
 
3
 
 as adjuvant. A tail bleed was obtained 1 wk
before the start of immunization (prebleed), and a total bleed was
obtained by cardiac puncture 1 wk after the last injection (final
bleed). The proteolytic activity of Der
 
 
 
p
 
 
 
1 and its inhibition with
E-64 or iodoacetamide in the immunization mixture were ascer-
tained as described above.
 
Antibody Detection.
 
Serum samples were initially titrated to
determine the optimal dilution for testing each antibody isotype
and subclass. The optimal dilutions used here were 1/10 for de-
tecting total IgE, Der
 
 
 
p
 
 
 
1–specific IgE, and OVA-specific IgE and
1/20,000, 1/40,000, and 1/250 for detecting Der
 
 
 
p
 
 
 
1–specific
IgG, IgG1, and IgG2b, respectively. Total IgE was detected by a
sandwich ELISA using one monoclonal anti–mouse IgE (clone
R35-72; PharMingen) as capture antibody and a second biotiny-
lated monoclonal anti–mouse IgE (clone R35-118; PharMingen)
as a detection antibody. Der
 
 
 
p
 
 
 
1–specific IgE, OVA-specific IgE
(measured using samples that have been depleted of IgG on a pro-
tein G column [Pharmacia]), and Der
 
 
 
p
 
 
 
1–specific IgG, IgG1, and
IgG2b were detected on microtiter plates coated with a 4 
 
m
 
g/ml
solution of either Der
 
 
 
p
 
 
 
1 or OVA and developed with biotiny-
lated (for IgE clone R35-118 and IgG1 clone A85-1 [PharMingen]
and for IgG2b clone AB275 [The Binding Site]) or alkaline phos-
phatase–conjugated isotype-specific antibodies (for IgG; Sigma
Chemical Co.). Alkaline phosphatase–conjugated Extravidine
(Sigma Chemical Co.) was used in conjunction with biotinylated
antibodies. Unpaired Student’s 
 
t
 
 test was used to compare levels
of antibody responses between the different immunization groups;
 
P 
 
, 
 
0.05 was considered significant.
 
Results and Discussion
 
Der
 
 
 
p
 
 
 
1 is a 25-kD cysteine protease whose structure has
been modeled (7) on the crystal structure of papain, with
which it shows considerable sequence similarities, most no-
tably for residues involved in the enzyme active site (8).
The proteolytic activity of Der
 
 
 
p 1 can be inhibited by
E-64, the class-specific inhibitor of microbial origin (9).
This inhibition is brought about when cysteine within the
Der p 1 active site forms a thioether covalent bond with the
epoxy group of E-64. This is an irreversible process that
Figure 1. Assessment of the purity of the Der p 1 preparation. NH2-
terminal sequencing showed that the sequence obtained (TNACSIN-
GNA) matches the published sequence of Der p 1 (8). (a) Silver-stained
SDS-PAGE analysis showing crude extract of fecal pellets (lane 1), frac-
tion obtained after immunoaffinity chromatography on immobilized anti–
Der p 1 mAb 4C1 followed by removal of contaminating serine proteases
on immobilized soybean trypsin inhibitor (lane 2), and the final product
after FPLC (lane 3). Molecular mass standards are indicated at left. (b)
Progression curves of the catalytic activity of Der p 1, measured in a con-
tinuous rate (kinetic) assay using the fluorogenic peptide substrate Boc-
Gln-Ala-Arg-AMC (6), with or without preactivation with cysteine. (c)
The addition of E-64 and iodoacetamide results in 100 and 94% inhibi-
tion of the enzymatic activity of Der p 1, respectively. Data presented in b
and c are the means of duplicate experiments; SE was ,5%.1899 Gough et al. Brief Definitive Report
does not lead to significant structural changes, as evidenced
by crystallographic studies of a papain–E-64 complex (10).
We have purified Der p 1 from fecal pellets using a mul-
tistep procedure and confirmed its purity by NH2-terminal
sequencing, SDS-PAGE analysis, and demonstration that
enzymatic activity was completely dependent on preactiva-
tion with cysteine and inhibited by E-64 and iodoaceta-
mide (Fig. 1). We have recently shown that Der p 1 selec-
tively cleaves human CD25 from the surfaces of peripheral
blood T cells (4). Here we demonstrate that Der p 1 also
selectively cleaves CD25 from cultured mouse spleen T cells
(Fig. 2), which is not surprising given the high degree of
sequence homology that exists between human (11) and
mouse (12) CD25. This observation has therefore provided
the justification for using this animal species for testing our
hypothesis, namely that the proteolytic activity of Der p 1
is a major contributor to its allergenicity.
Intraperitoneal immunization of groups of 10 CBA/J
mice with either proteolytically active or inactive (E-64–
blocked) Der p 1 over a 6-wk period showed a statistically
significant enhancement in total IgE (P , 0.01) and Der p
1–specific IgE (P , 0.02) responses in animals immunized
with proteolytically active Der p 1. This effect was IgE spe-
cific, as Der p 1–specific IgG, IgG1, and IgG2b responses
increased to the same extent with proteolytically active or
inactive Der p 1 (Fig. 3). We are not sure why the IgG1 re-
sponse did not follow that of IgE, as these two isotypes are
considered to be coregulated in the mouse. However, the
IgE-restricted enhancement seen in response to immuniza-
tion with proteolytically active Der p 1 does suggest a mech-
anism that is unique to IgE isotype switching/synthesis. Fur-
Figure 2. Proteolytically active Der  p  1 (10 mg/ml) cleaves mouse
CD25, but not CD3, CD4, or CD8, from spleen T cells as monitored by
flow cytometry (a); cleavage of CD25 is dose dependent (b). No such ef-
fect was demonstrable when Der p 1 was inactivated by E-64. Data pre-
sented are the means of duplicate experiments; SE was ,5%.
Figure 3. Total IgE (a) and Der p 1–specific IgE (b), IgG (c), IgG1 (d),
and IgG2b (e) levels in final bleeds obtained from groups of 10 mice im-
munized with proteolytically active or inactive (E-64–blocked) Der p 1
measured by ELISA. There was a statistically significant enhancement in
total IgE (P , 0.01) and Der p 1–specific IgE (P , 0.02) responses in an-
imals immunized with proteolytically active Der p 1; prebleeds showed
no measurable levels of antibody (except for baseline levels of total IgE).
Depleting serum samples of IgG by protein G treatment (to overcome
competition) from animals immunized with proteolytically active Der p 1
enhances the detection of Der p 1–specific IgE (f); this effect was also ob-
served with animals immunized with proteolytically inactive Der p 1. Er-
ror bars represent 95% confidence intervals, and the results are representa-
tive of two immunization experiments.1900 Der p 1 Enhances IgE
thermore, our control experiments clearly show that the
IgE-specific effect observed here is not due to E-64 exert-
ing a suppressive influence on IgE production by a mecha-
nism that is independent of its binding to the Der p 1 en-
zyme active site (Fig. 4). First, suppression of total IgE (P ,
0.04) and Der p 1–specific IgE (P , 0.05) productions was
also obtained when the proteolytic activity of Der p 1 was
blocked with iodoacetamide, another sulfhydryl reactive
agent. Second, the IgE antibody response to OVA, a pro-
teolytically inactive antigen, was not suppressed when the
animals were immunized with OVA plus E-64.
Our results are direct evidence that the cysteine protease
activity of Der p 1 induces a significant increase in IgE re-
sponses. Such an effect is clearly consistent with the ability
of Der p 1 to proteolytically cleave mouse CD25 and in-
duce a Th2 response by modulating the balance between
IL-4 and IFN-g (13). The recent demonstration in mice
that Leishmania mexicana cysteine proteinase–deficient mutants
potentiate a Th1 response, compared with the Th2 response
normally seen in response to infection with wild-type para-
site (14), is also of great relevance here. These findings sug-
gest that immune deviation toward Th1 in dust mite–allergic
individuals could potentially be achieved by administering
Der p 1 in a catalytically inactive (mutant) form. On the other
hand, exploring the potential Th2 adjuvant property of the
proteolytic activity of Der p 1 would have important impli-
cations in defining principles for modulation of Th1-medi-
ated pathological conditions.
Our demonstration that the cysteine protease activity of
Der p 1 enhances total IgE production, apart from increasing
Der p 1-specific IgE, suggests that this allergen may play a
central role in destabilizing the microenvironment within
target tissues to one that is proallergic and thus aids in the
initiation and propagation of the allergic cascade. In other
words, the proteolytic activity of Der p 1 may exert an IgE-
specific adjuvant effect. The in vivo relevance of the pro-
teolytic activity of Der p 1 is further highlighted by reports
demonstrating that it increases the permeability of the hu-
man respiratory epithelium to macromolecules (15, 16). Such
observations, together with our current findings showing a
direct effect on the immune system, indicate that the pro-
teolytic activity of Der p 1 is a major contributor to its al-
lergenicity.
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